These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 126368)

  • 1. [Letter: "Basis therapy" and especially "cell therapy" in Down's syndrome].
    Betke K; Schäfer KH
    Monatsschr Kinderheilkd (1902); 1975 Sep; 123(9):667-71. PubMed ID: 126368
    [No Abstract]   [Full Text] [Related]  

  • 2. [Letter: Comment on cell therapy in children with special reference to pediatric-metabolic problems].
    Bremer HJ
    Monatsschr Kinderheilkd (1902); 1975 Sep; 123(9):674-5. PubMed ID: 126370
    [No Abstract]   [Full Text] [Related]  

  • 3. [Letter: Comment on therapy of Down's syndrome, especially on cell therapy from the neurophysiological/neuropediatric viewpoint].
    Schulte FJ
    Monatsschr Kinderheilkd (1902); 1975 Sep; 123(9):683-5. PubMed ID: 126373
    [No Abstract]   [Full Text] [Related]  

  • 4. [Letter: Comment on therapy of Down's syndrome from the cytogenetic and clinical viewpoints].
    Pfeiffer RA
    Monatsschr Kinderheilkd (1902); 1975 Sep; 123(9):678-83. PubMed ID: 126372
    [No Abstract]   [Full Text] [Related]  

  • 5. [Letter: Comment on fresh-cell therapy of children with special reference to Down's syndrome and other cerebral damages].
    Hitzig WH
    Monatsschr Kinderheilkd (1902); 1975 Sep; 123(9):676-8. PubMed ID: 126371
    [No Abstract]   [Full Text] [Related]  

  • 6. The metabolism of vitamin B6 in Down's syndrome.
    McCoy EE; Colombini C; Ebadi M
    Ann N Y Acad Sci; 1969 Sep; 166(1):116-25. PubMed ID: 4243377
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood-serotonin deficiency in Down's syndrome.
    Tu JB; Zellweger H
    Lancet; 1965 Oct; 2(7415):715-6. PubMed ID: 4157774
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased activity of pyridoxal kinase in tongue in Down's syndrome.
    Coburn SP; Mahuren JD; Schaltenbrand WE
    J Ment Defic Res; 1991 Dec; 35 ( Pt 6)():543-7. PubMed ID: 1839316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Letter: Comment on indication for fresh or sicca-cell therapy of mongolism from the pediatric-endocrinologic viewpoint].
    Bierich JR
    Monatsschr Kinderheilkd (1902); 1975 Sep; 123(9):671-4. PubMed ID: 126369
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on the state of vitamins B1, B2 and B6 in Down's syndrome].
    Schmid F; Christeller S; Rehm W
    Fortschr Med; 1975 Sep; 93(25):1170-2. PubMed ID: 129424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The feasibility of treating Down's disease with a reduced phenylalanine diet.
    Marsh RW
    N Z Med J; 1971 Aug; 74(471):116-7. PubMed ID: 4260154
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood phospholipids in patients with Down's disease].
    Aitbaev KA
    Sov Zdravookhr Kirg; 1973; 6():18-20. PubMed ID: 4273356
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the L-tryptophan metabolism in children with Down's syndrome].
    Vassella F; Colombo JP; Gloor RD; Rossi E
    Helv Paediatr Acta; 1968 Aug; 23(4):419-28. PubMed ID: 4234242
    [No Abstract]   [Full Text] [Related]  

  • 14. Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model.
    Guidi S; Stagni F; Bianchi P; Ciani E; Giacomini A; De Franceschi M; Moldrich R; Kurniawan N; Mardon K; Giuliani A; Calzà L; Bartesaghi R
    Brain; 2014 Feb; 137(Pt 2):380-401. PubMed ID: 24334313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc may be a double-faced Janus to Down's syndrome patients.
    Zatta P
    Biol Trace Elem Res; 2000 Jan; 73(1):93-4. PubMed ID: 10949973
    [No Abstract]   [Full Text] [Related]  

  • 16. Fate of 14C-labelled tryptophan and 5-hydroxytryptophan in Down's syndrome.
    Airaksinen EM; Airaksinen MM; Pentikäinen P
    Ann Clin Res; 1973 Dec; 5(6):385-91. PubMed ID: 4275982
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of 5-HTP in the treatment of Down's syndrome.
    Weise P; Koch R; Shaw KN; Rosenfeld MJ
    Pediatrics; 1974 Aug; 54(2):165-8. PubMed ID: 4277102
    [No Abstract]   [Full Text] [Related]  

  • 18. Failure of vitamin mineral supplementation in Down's syndrome.
    Smith GF; Spiker D; Peterson C; Cicchetti D; Justice P
    Lancet; 1983 Jul; 2(8340):41. PubMed ID: 6134900
    [No Abstract]   [Full Text] [Related]  

  • 19. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
    N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Letter: Institutionalization of children with Down's syndrome].
    Engbaek S
    Ugeskr Laeger; 1976 Jun; 138(25):1544-5. PubMed ID: 132728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.